Texas Yale Capital Corp’s Teva Pharmaceuticals TEVA Stock Holding History

Texas Yale Capital Corp’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-10,200	Closed	-$469K	–	447
2016 Q3	$469K	Hold	10,200	–	–	0.05%	317
2016 Q2	$512K	Hold	10,200	–	–	0.05%	300
2016 Q1	$546K	Hold	10,200	–	–	0.06%	277
2015 Q4	$670K	Hold	10,200	–	–	0.06%	243
2015 Q3	$576K	Hold	10,200	–	–	0.05%	276
2015 Q2	$603K	Hold	10,200	–	–	0.05%	292
2015 Q1	$635K	Hold	10,200	–	–	0.05%	291
2014 Q4	$587K	Buy	+10,200	New	+$568K	0.05%	291

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Texas Yale Capital Corp's TEVA Position: Q4 2016 in Review

Texas Yale Capital Corp sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 10,200 shares — an estimated $469K sold.

Texas Yale Capital Corp first reported a position in TEVA in Q4 2014 and held it in 8 quarters. The position peaked at $670K in Q4 2015. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Texas Yale Capital Corp reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Texas Yale Capital Corp sold 10,200 Teva Pharmaceuticals shares in Q4 2016, an estimated $469K.
Texas Yale Capital Corp first reported a position in Teva Pharmaceuticals in Q4 2014 and held it in 8 quarters.
Texas Yale Capital Corp's Teva Pharmaceuticals position peaked at $670K in Q4 2015.
737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Texas Yale Capital Corp's 13F filing for Q4 2016, filed 13 Feb 2017.